Benzinga's Top Downgrades

Analysts at Bank of America downgraded Vitamin Shoppe

from “neutral” to “underperform.” The target price for Vitamin Shoppe has been lowered from $55 to $40. Vitamin Shoppe's shares closed at $45.23 yesterday. Analysts at Oppenheimer downgraded CA Technologies

from “outperform” to “perform.” CA's shares closed at $27.77 yesterday. Analysts at Cantor Fitzgerald downgraded ValueClick

from “buy” to “hold.” The price target for ValueClick has been lowered from $32 to $31. ValueClick's shares closed at $31.74 yesterday. Goldman Sachs downgraded Zillow

from “buy” to “neutral.” The target price for Zillow has been raised from $60 to $67. Zillow's shares closed at $62.94 yesterday.